Osteochondral Lesion of Talus Clinical Trial
Official title:
The Effects of Monitoring Weight Bearing Protocols Following Lower Extremity Surgeries Via Mobile Application and Pressure Sensors.
Verified date | August 2022 |
Source | Marmara University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Randomized, prospective, double-blind study: Avascular, anöral and non-regenerative cartilage tissue mostly repaired via arthroscopic surgeries. After that, the patients rehabilitate with optimum weight bearing protocols in post-operative and discharge periods by physiotherapists. In the post-operative period, optimum weight bearing is vital for this tissue healing. There is not any opportunity or device to follow up the compliance of patients to weight bearing. We aimed to develop a device with mobile application to monitor the compliance the patients to weight bearing protocols. This device is designed to could give negative live feedback (with visual audible and vibrating warnings) in order to ensure the compliance of patients. Thanks to the device, health professionals will also have the opportunity to monitor the patient's compliance with the protocol on a daily basis. We hypothesized that patients monitored with this device may have a better recovery.
Status | Completed |
Enrollment | 10 |
Est. completion date | August 10, 2022 |
Est. primary completion date | May 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Patients with a symptomatic osteochondral lesion of the Talus. - Magnetic resonance of the ankle showing osteochondral injury of a single talus - People who can use smart phone (andoid or ios) Exclusion Criteria: - Recurrent osteochondral lesions of the talus - Multiple osteochondral lesions - Severe ankle instability, requiring open repair - History of a previous foot or ankle surgery of the ipsilateral foot - Having a systematic disorders like Diabetes Mellitus, Rheumatoid arthritis etc. - Inability to return to the surgery site to practice long-term follow-up evaluations or lack of readiness to complete the indicated evaluation forms. - Patients with a qualitative or quantitative commitment that prevents consent or assent their participation in the study. |
Country | Name | City | State |
---|---|---|---|
Turkey | Marmara University | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Marmara University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Monitoring the compliance with weight bearing protocol | number of times above the specified upper threshold, the number of failures to reach the specified lower threshold, percentage of steps in correct weight bearing range parameter will be monitored by the device (insole with pressure sensors) | Post-op every day for 6 weeks | |
Other | Visual Analog Scale | Visual Analog Scale for Pain (VAS-Pain): a pain rating scale based on self-reported measures of symptoms. A 10cm line numbered from 0 to 10 represents a continuum between "no pain" (zero) and "worst pain" (ten). It can also be interpreted as a 0-to-100 points score.
This scale will be used for assessment of patient's pain levels after activity and at rest |
Post-op every day for 6 weeks, post-op 12 week, post-op 24 week | |
Primary | Evaluation the clinical recovery of osteochondral lesion of talus post operative patients. | American Orthopedic Foot and Ankle Society- Ankle hindfoot scale will be used for this evaluation. The scale includes nine items that can be divided into three sub-scales (pain, function and alignment). Pain consists of one item with a maximal score of 40 points, indicating no pain. Function consists of seven items with a maximal score of 50 points, indicating full function. Alignment consists of one item with a maximal score of 10 points, indicating good alignment. The maximal score is 100 points, indicating no symptoms or impairments. This scale will be used for evaluation the clinical recovery of osteochondral lesion of talus post operative patients. | pre-operative day, post-op 6 week, post-op 12 week, post-op 24 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04475341 -
Osteochondral Lesions Under 15mm2 of the Talus; is Iliac Crest Bone Marrow Aspirate Concentrate the Key to Success?
|
N/A | |
Enrolling by invitation |
NCT03856021 -
Microfracture vs. Microfracture and BMAC for Osteochondral Lesions of the Talus
|
N/A | |
Not yet recruiting |
NCT05476692 -
Clinical Outcome of Surgical Treatment for Osteochondral Lesions of the Talus
|
||
Active, not recruiting |
NCT02345564 -
Clinical and Radiological Results of Osteochondral Repair Using MaioRegen in Knee and Ankle Surgery
|
N/A | |
Active, not recruiting |
NCT01347892 -
DeNovo NT Ankle LDC Study
|
N/A | |
Active, not recruiting |
NCT03750253 -
Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus
|
N/A | |
Recruiting |
NCT06358807 -
Microfracture With Platelet Rich Plasma Gel Injection for Osteochondral Lesion of the Talus
|
N/A | |
Enrolling by invitation |
NCT02338375 -
Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product
|
Phase 0 | |
Withdrawn |
NCT05741983 -
AMIC vs. MFx in the Ankle
|
N/A | |
Enrolling by invitation |
NCT04132076 -
Treatment Outcome After Ankle Joint Surgeries
|